Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.
Standard
Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis. / Stölting, S; Klink, Thorsten; Bela, C; Engels, C; Wagner, T.
in: INT J CLIN PHARM TH, Jahrgang 42, Nr. 11, 11, 2004, S. 652-653.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.
AU - Stölting, S
AU - Klink, Thorsten
AU - Bela, C
AU - Engels, C
AU - Wagner, T
PY - 2004
Y1 - 2004
KW - Animals
KW - Humans
KW - Mice
KW - Tumor Cells, Cultured
KW - Drug Administration Schedule
KW - Mice, Nude
KW - Transplantation, Heterologous
KW - Lung Neoplasms/drug therapy
KW - Antineoplastic Agents, Alkylating/administration & dosage/therapeutic use
KW - Carcinoma, Non-Small-Cell Lung/drug therapy
KW - Cyclophosphamide/administration & dosage/analogs & derivatives/therapeutic use
KW - Neovascularization, Pathologic/prevention & control
KW - Animals
KW - Humans
KW - Mice
KW - Tumor Cells, Cultured
KW - Drug Administration Schedule
KW - Mice, Nude
KW - Transplantation, Heterologous
KW - Lung Neoplasms/drug therapy
KW - Antineoplastic Agents, Alkylating/administration & dosage/therapeutic use
KW - Carcinoma, Non-Small-Cell Lung/drug therapy
KW - Cyclophosphamide/administration & dosage/analogs & derivatives/therapeutic use
KW - Neovascularization, Pathologic/prevention & control
M3 - SCORING: Journal article
VL - 42
SP - 652
EP - 653
IS - 11
M1 - 11
ER -